Cited by 686Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and LipoproteinsDialysis and Renal Disease Management

The DOI matches its Crossref record; 108 of the 111 references it cites were found in a registry or an index.

The Global Epidemiology of Diabetes and Kidney Disease

Open access

Koye, Digsu N., Magliano, Dianna J., Nelson, Robert G., Pavkov, Meda E.·2018·Advances in Chronic Kidney Disease

DOI 10.1053/j.ackd.2017.10.011PMC PMC11000253

Open this paper in CoChat — free account

Abstract

The prevalence of diabetes is increasing worldwide, with the greatest increases occurring in low- and middle-income countries. In most developed countries, type 2 diabetes is presently the leading cause of end-stage renal disease and also contributes substantially to cardiovascular disease. In countries with weaker economies type 2 diabetes is rapidly replacing communicable diseases as a leading cause of kidney disease and is increasingly competing for scarce health care resources. Here, we present a narrative review of the prevalence and incidence of diabetes-related kidney disease worldwide. Mortality among those with diabetes and kidney disease will also be explored. Given the high morbidity and mortality associated with chronic kidney disease, we will also examine the level of awareness of this disease among people who have it.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.ackd.2017.10.011

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00618-8 · Cited by 4,311
Type 1 diabetes
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Robinson, B. M., Abbott, K. C., Agodoa, L. Y. C., Albertus, P., Ayanian, J. Z., Balkrishnan, R., Bragg‐Gresham, J. L., Cao, J., Chen, J. L. T., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.004 · Cited by 2,192

Flagged first, then by citations

Show all 111 references

3 of the 111 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

2018, 2017 USRDS Annual Data Report: Executive Summary. Chapter 2: Identification and Care of Patients With CKD, Am J Kidney Dis, 71, S31

Sorted by citations

Items 601–684 of 684

Evaluation of sarcopenia in nonelderly patients with diabetes mellitus and its association with poor glycemic controlPreprint
Daloğlu, O. O., Ünal, M. Ç., Guller, P. U., Alak, Z. Y. Ş., Güçlü, M., & Kiyici, S. K. (2025) · Research Square · doi:10.21203/rs.3.rs-5925053/v2 · Cited by 1
Mesangial angiogenesis and interstitial eosinophilic infiltration in diabetic nephropathy are associated with elevated CD248 expression
Li, X., Zhang, J., Wang, Y., Yu, T., Jiang, S., Gao, Y., Zhang, H., & Li, W. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2510552
Performance of the Kidney Failure Risk Equation according to diabetic status in the CKD-CAREMEAU cohort of patients with chronic kidney disease
Prouvot, J., Reboul, P., Ahmadpoor, P., Clemmer, E., Gerbal, M., Garo, F., Cariou, S., Pambrun, E., Messikh, Z., & Moranne, O. P. (2025) · Journal of Nephrology · doi:10.1007/s40620-025-02286-6
Ribosomes under stress: GCN2 integrates translational dysfunction and pain signaling
Rodríguez-Palma, E. J., & Khanna, R. (2025) · Pain · doi:10.1097/j.pain.0000000000003762
Diabetic Kidney Disease: A Versatile Disease
Granados‐Silvestre, M. D. L. Á., Ortiz‐López, M. G., & Sanchez-Pozos, K. A. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815305692125010013
Relationship between flow-mediated dilation and urinary albumin-creatinine ratio in patients with type 2 diabetes mellitus
Fang, Y., Jing, L., Zhu, Y., Wang, H., Xia, J., Lei, T., Lu, J., & Gao, J. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109162 · Cited by 1
Real-world implementation of the 2020 KDIGO guidelines for diabetes management in chronic kidney disease: a single-center retrospective study
Levin-Iaina, N., El’Nasasra, H., & Benaim, A. R. (2025) · Frontiers in Nephrology · doi:10.3389/fneph.2025.1664369
The role of vegan meat as an alternative protein source in chronic kidney disease: a narrative review
Sharma, L., & Banerjee, D. (2025) · Discover Food · doi:10.1007/s44187-025-00625-x
Impact of Denosumab Adherence on Renal Function and Mortality Rates in Type 2 Diabetes Patients With Osteoporosis
Chang, Y.-C., Chen, J.-C., Lin, S.-Y., Lin, K., Ho, P.-S., Chen, C.-H., Fu, Y.-C., & Lee, T.-C. (2025) · Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.70124
Comment on “Analysis of acute glomerulonephritis disease burden and incidence trends in China, 1990–2021”
Khan, A., Muhammad, W., Khan, M. A., Bhatti, M. I., Karishma, F., & Karim, A. (2025) · International Urology and Nephrology · doi:10.1007/s11255-025-04836-0
Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Kidney Transplant Recipients: Impact on Glycemic Control, Graft Function, and Proteinuria
Rossi, M. R., Kawai, L. H. R., Mazzali, M., & de Sousa, M. V. (2025) · Brazilian Journal of Transplantation · doi:10.53855/bjt.v28i1.717_eng
Inibidores do Cotransportador Sódio-Glicose 2 em Receptores de Transplante Renal Diabéticos: Impacto no Controle Glicêmico, Função do Enxerto e Proteinúria
Rossi, M. R., Kawai, L. H. R., Mazzali, M., & de Sousa, M. V. (2025) · Brazilian Journal of Transplantation · doi:10.53855/bjt.v28i1.717_port
Understanding the burden and associated risk factors of type 2 diabetes mellitus among middle-aged and aging population in Yangon, Myanmar: a cross-sectional analytical study
Htike, K. M., Thi, W. M., & Kumar, R. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01768-5
Metabolomic etiological insights into six diabetic complications: a large scale Mendelian randomization atlas with colocalization validation
Su, M., Si, X., & Tian, L. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02595-z
The possible renoprotective effect of denatonium benzoate in a rat model of type 2 diabetes: role of Krüppel-like factor 6 (KLF6)
Mohammed, H. S. Z., Elfetiany, O. S., Omar, W. E., & Roushdy, W. N. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04704-9
Effect of Tofogliflozin on Urinary Albumin-to-Creatinine Ratio vs. Metformin in Diabetic Kidney Disease: Rationale and Study Protocol of the TRUTH-DKD Trial
Kimura, K., TAKAGI, Y., Harada, M., Ueda, S., Minamisawa, M., Sonoda, K., Oiwa, A., Yazaki, Y., Sakurai, S., Tomita, T., et al. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01822-8
Association of growth differentiation factor-15 with renal disease outcomes and all-cause death in type 1 and type 2 diabetic patients: a meta-analysis
Huang, X., Yu, N., Yu, H., & Yang, S. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04624-z
Impact of Type 2 Diabetes Mellitus on Age at Death in the Hemodialysis Population: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
You, J. H., Son, K. J., Park, K. S., Lee, B., & Song, S. O. (2025) · Diabetology · doi:10.3390/diabetology6120145
Renal manifestations and diabetes mellitus: the missing link
Akpalu, J., Boima, V., & Abobi-Kanbigs, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33090-2.00009-6
Additional file 2 of Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
Su, P.-P., Liu, D.-W., Zhou, S., Chen, H., Wu, X.-M., & Liu, Z.-S. (2022) · Figshare · doi:10.6084/m9.figshare.19881431
Additional file 1 of ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response
Liu, Y., Zhang, L., Zhang, S., Liu, J., Li, X., Yang, K., Danyi, Y., Liu, Y., Sun, L., 刘伏友, et al. (2023) · Figshare · doi:10.6084/m9.figshare.22688753
Additional file 2 of Changes in glucose metabolism, C-reactive protein, and liver enzymes following intake of NAD + precursor supplementation: a systematic review and meta‐regression analysis
Sohouli, M. H., Tavakoli, S., Reis, M. G., Hekmatdoost, A., & Guimarães, N. S. (2024) · Figshare · doi:10.6084/m9.figshare.26094488
Additional file 3 of Changes in glucose metabolism, C-reactive protein, and liver enzymes following intake of NAD + precursor supplementation: a systematic review and meta‐regression analysis
Sohouli, M. H., Tavakoli, S., Reis, M. G., Hekmatdoost, A., & Guimarães, N. S. (2024) · Figshare · doi:10.6084/m9.figshare.26738268
Additional file 1 of Efficacy evaluation of Berberis aristata and Silybum marianum fixed dose combination on glycaemic and insulin resistance parameters in adult population: a systematic review and meta-analysis of randomized controlled trials
Dubey, V. P., Kansagra, J. J., Sureja, V., & Kheni, D. (2024) · Figshare · doi:10.6084/m9.figshare.26686359
Additional file 4 of Changes in glucose metabolism, C-reactive protein, and liver enzymes following intake of NAD + precursor supplementation: a systematic review and meta‐regression analysis
Sohouli, M. H., Tavakoli, S., Reis, M. G., Hekmatdoost, A., & Guimarães, N. S. (2024) · Figshare · doi:10.6084/m9.figshare.26738271
Additional file 1 of Association between neck circumference and diabetes mellitus: a systematic review and meta-analysis
Li, D., Zhao, Y., Zhang, L., You, Q., Jiang, Q., Yin, X., & Cao, S. (2023) · Figshare · doi:10.6084/m9.figshare.23550232
Additional file 1 of Changes in glucose metabolism, C-reactive protein, and liver enzymes following intake of NAD + precursor supplementation: a systematic review and meta‐regression analysis
Sohouli, M. H., Tavakoli, S., Reis, M. G., Hekmatdoost, A., & Guimarães, N. S. (2024) · Figshare · doi:10.6084/m9.figshare.26094402
Additional file 1 of The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials
Alsalemi, N., Sadowski, C. A., Elftouh, N., Louis, M., Kilpatrick, K., Houle, S. K. D., & Lafrance, J. (2022) · Figshare · doi:10.6084/m9.figshare.19681822
Additional file 1 of Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
Su, P.-P., Liu, D.-W., Zhou, S., Chen, H., Wu, X.-M., & Liu, Z.-S. (2022) · Figshare · doi:10.6084/m9.figshare.19881428
Additional file 3 of The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials
Alsalemi, N., Sadowski, C. A., Elftouh, N., Louis, M., Kilpatrick, K., Houle, S. K. D., & Lafrance, J. (2022) · Figshare · doi:10.6084/m9.figshare.19681828
Additional file 2 of The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials
Alsalemi, N., Sadowski, C. A., Elftouh, N., Louis, M., Kilpatrick, K., Houle, S. K. D., & Lafrance, J. (2022) · Figshare · doi:10.6084/m9.figshare.19681825
Synergizing CDIO Framework and Sustainable Development Goals in Psychological Assessment
Dizon, A. R. A. (2025) · International Journal of Basic and Applied Sciences · doi:10.14419/qbyqtb59
Comparative study of prevalence and predictors of altered bone mineral density in type 2 diabetes mellitus and diabetic kidney disease: A single-center analysis
Varshney, S., Aslam, M., Husain, A., Ashraf, H., Raza, A., & Fatima, R. (2025) · International Journal of Noncommunicable Diseases · doi:10.4103/jncd.jncd_122_25
O papel dos probióticos na modulação da microbiota intestinal como potencial inibidor da progressão da doença renal diabética
Costa, V. C. S., Pinheiro, M. M., Cabreira, G. T., Bustelli, I. B., Santos, J. F., Ventura, S., Santos, L. S. C., Vattimo, M. D. F. F., & Silva, E. D. O. (2026) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2025-0143pt
Multimodal psychological intervention improves psychological well-being and inflammatory profiles in patients with diabetic nephropathy
Tang, H., & Liu, S. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168171
Proteomic profiling of arteriovenous fistula tissue identifies dysregulated oxidoreductase proteins in diabetic end-stage renal disease
Zhao, B., Zhan, S., Zhou, X., Yu, P., & Wang, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1583065
Intravascular lithotripsy for calcified femoropopliteal artery disease: A pooled analysis of randomized trials in a Chinese population
Du, G., Jin, Y., Qiu, P., Wu, X., Wang, R., & Lu, X. (2026) · JVS-Vascular Insights · doi:10.1016/j.jvsvi.2026.100376
The neutrophil percentage to albumin ratio as a predictor of all-cause and cardiovascular mortality in patients with diabetic kidney disease: A longitudinal cohort analysis of NHANES 2009 to 2018
Tao, W., Yu, Y., Tan, D., & Yu, R. (2026) · Medicine · doi:10.1097/md.0000000000047586
Role of Nephropathological Factors with Fibrinogen in the Progression of Human Diabetic Nephropathy in the Pakistani Population
Maqsood, M., Sharif, S., Saqib, M., Maqsood, M., Naz, S., Rafaqat, S., & Hasan, A. (2026) · Current Diabetes Reviews · doi:10.2174/0115733998433035251219191845
Diabetic kidney disease in northwest Ethiopia: Prevalence and determinants among adults with type 2 diabetes
Hailu, W., Dejene, T. A., Medhin, M. T. G., Molla, M. D., Birru, E. M., Alemu, S., & Awoke, T. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343210
Association of TyG index and ALOX12 rs112667 polymorphism with T2DM and DKD in Chinese adults
Yin, Y., Yang, M., Deng, W., & Zheng, W. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01919-2
Temporal Progression of Microvascular Alterations in the Nailfold and Skeletal Muscle of Non‐Obese Type 2 Diabetic Rats
Kanazashi, M., Tanaka, M., & Tsumori, T. (2026) · Microcirculation · doi:10.1111/micc.70054
The diagnostic value of immune-inflammatory markers for diabetic kidney disease in type 2 diabetic patients: a meta-analysis
Wang, Y., Liu, X., & Zhenwen, X. I. A. O. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1811189
Impact of Sodium-glucose Co-transporter 2 Inhibitors on Bone Mineral Biomarkers and Renal Progression in Diabetic Kidney Disease: A Prospective Observational Study
Chaudhary, K., Aslam, M., Husain, A., Ashraf, H., Raza, A., Fatima, R., & Nagvanshi, M. R. (2026) · Indian Journal of Kidney Diseases · doi:10.4103/ijkd.ijkd_41_25
Association between life course adiposity and diabetic microvascular complications: A univariable and multivariable Mendelian randomization study
Ma, J., Hao, M., Yao, J., Li, Y., & Liu, T. (2026) · Medicine · doi:10.1097/md.0000000000048247
Effects of individual sodium-glucose cotransporter-2 inhibitors on all-cause mortality in patients with diabetic kidney disease
Nobayashi, H., Satoh, M., Hirose, T., Nakayama, S., Iwabe, Y., Yagihashi, T., Hashimoto, H., Murakami, T., Okada, K., Mori, T., et al. (2026) · Clinical and Experimental Nephrology · doi:10.1007/s10157-026-02865-2
Interrelationships Between Key Cardiovascular Risk Factors, Chronic Kidney Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease
Muzurović, E. M., Zečević, K., & Mikhailidis, D. P. (2026) · Current Cardiology Reports · doi:10.1007/s11886-026-02367-3
Low visceral fat and kidney disease risk in men with diabetes
Zoccali, C., & Mallamaci, F. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00045-8
Characterization of NLRP3 Inflammasome‐Associated Hub Genes in the Progression of Diabetic Nephropathy
Zhao, S., Li, Y., Li, W., Dong, L., Lian, R., Luo, Q., 连兴基, Li, J., & He, F. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70424
Endocan level and its association with glycemic and inflammatory indices in diabetic nephropathy
Al-Mayahi, L. M., & Shammaree, S. A. W. A. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02274-2
The Impact of Chronic Kidney Disease on Ulcer-Related Outcomes in Hospitalized Diabetic Foot Ulcers
Sripatpong, J., Krittiyawong, S., Chatchomchuan, W., Wanothayaroj, E., Srikummoon, T., Klinoubol, P., Chotwanvirat, P., Butadej, S., Nakasatien, S., Himathongkam, T., et al. (2026) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.041.01.5197
Serum metabolomic profiling by 1H NMR reveals distinct metabolic signatures in diabetic and non-diabetic chronic kidney disease
Sahu, A., Gupta, U., Baishya, B., Kaul, A., Yadav, S., & Sinha, N. (2026) · Biophysical Chemistry · doi:10.1016/j.bpc.2026.107641
Urinary Podocalyxin as a Candidate Biomarker for Early Diabetic Nephropathy: Findings from a Cross-sectional Study
Suja, A. B., Nair, B. G., Stary, G. P., & Geetha, R. R. (2026) · Indian Journal of Medical Biochemistry · doi:10.5005/jp-journals-10054-0275
Diabetic Kidney Disease and Diabetic Retinopathy: Correlation, Retinal Biomarkers, and the Role of Artificial Intelligence
Rajalakshmi, R., Pradeepa, R., Anjana, R. M., Sivaprasad, S., Baskar, V., & Viswanathan, M. (2026) · Journal of Diabetology · doi:10.4103/jod.jod_8_26
Prevalence of nephropathy in type 2 diabetes patients in the Eastern Mediterranean Region: A systematic review and meta-analysis
Zeighami, S., Shaabani, S., Moheb, M., Pakfetrat, M., Azarchehry, S. P., Dehghankhalili, S., Mirahmadizadeh, A., Sahebi, R., Keshavarzian, O., & Heiran, A. (2026) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2026.103438
Cardiovascular‐Kidney‐Metabolic Syndrome: Conceptualising an Approach to Health Economic Modelling
FOOS, V., Chen, J., McEwan, P. C., Evans, M., Jhund, P. S., Kalra, P. R., Hongtu Zhu, B., Wheeler, D. C., Roberts, G. M., Cowie, M., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70976
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant‐Level Exploratory Analysis of the Randomised CONFIDENCE Trial
McGill, J. B., Green, J., Heerspink, H. J. L., Mann, J. F. E., Mottl, A. K., Rosenstock, J., Rossing, P. R., Vaduganathan, M., Nangaku, M., BRINKER, M. D., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70949
Genetic and epigenetic landscape of type 2 diabetes mellitus
Patil, P. C., Surve, S., Kaleem, M., Bachhav, R. S., & Kayali, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33590-7.00012-5
Prognostic models for diabetic kidney disease outcomes: A systematic review
Yang, D., Fan, Y., Xu, Y., Jin, K., Ma, Y., & Wang, R. (2026) · Diabetic Medicine · doi:10.1111/dme.70391
Life’s Crucial 9, Weight-adjusted Waist Index, and Diabetic Kidney Disease Among US Adults: A Nationally Representative NHANES StudyPreprint
Li, X., Duan, J., Xie, C., Ma, X., & Jia, X. F. (2026) · Research Square · doi:10.21203/rs.3.rs-9996851/v1
Hydroxytyrosol attenuates STZ-induced nephropathy in pinealectomized rats: Associations with oxidative stress, inflammation, and SIRT1/Nrf2/GPX4-related responses
Cinar, D., Altınöz, E., Başak, F., Kuşat, T., Biçer, Y., & Üğe, M. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103796
A multimodal analysis suggests partial IRF8/TLR7-associated myeloid transcriptional convergence between diabetic kidney disease and Parkinson’s disease
Hu, X., Li, Y., Luo, B., Yang, W. Y., Xia, C., & wang, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0356691
Dapagliflozin modulates diabetic kidney disease through indirect transcriptional regulation rather than direct transcriptional reversal
Pesce, F., Strizzi, C. T., Granata, A., Bracaccia, M. E., Muzi, L., Liakopoulos, V., & Grandaliano, G. (2026) · Journal of Nephrology · doi:10.1093/joneph/aajag074
Navigating the kidney disease care cascade in type 2 diabetes: insights from the national diabetes registry
Yap, S. Y., Shah, S. A., Mustafar, R., & Hassan, N. (2026) · BMC Public Health · doi:10.1186/s12889-026-28520-9
From MyACR to MyμAlbumin: Clinical Validation of a High‐Precision, Real‐Time Immunoturbidimetric PoC Device for Early Chronic Kidney Disease Detection
Plengsuriyakarn, T., Chai่jaroenkul, W., Youngvises, N., Sirisabhabhorn, K., Bubpha, W., & Na‐Bangchang, K. (2026) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.70322
Mesenchymal stem cells and empagliflozin: a potential therapeutic approach for autophagy and Klotho modulation in diabetic kidney disease
Franco, M. L., Beyerstedt, S., Barbosa, B. S., Alves, T. M. R., Silva, A. F. D., Mariano, M. O., Carlos, A. K., Arjona, J. E., Josefi-Rocha, G. R., Bastos, R. M. C., et al. (2026) · Stem Cells · doi:10.1093/stmcls/sxag043
Incident Type 2 Diabetes in Individuals With CKD: The REGARDS Study
Li, X., Vélez, J. A. J., Kanney, N., Landrum, A., Edwards, L. J., Gutiérrez, O. M., Long, D. L., & Hidalgo, B. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101498
Association between neutrophil-to-HDL cholesterol ratio and diabetic nephropathy in adults with diabetes mellitus
Zhou, Y., & Zhu, J. (2026) · Medicine · doi:10.1097/md.0000000000050146
Preliminary Association of a Gut Corynebacterium stationis Isolate with Increased AGE‑Related Fluorescence and Early Renal Alterations in Rats
Patil, R. S., Rooge, S. B., & Arvindekar, A. U. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02621-3
Sex differences in trajectories to cardio-renal and mental health outcomes following the onset of type 2 diabetes: An observational cohort study using multi-state analysis in the UK Clinical Practice Research Datalink
Eto, F., Samuel, M., Stow, D., Henkin, R., Angdembe, A., Barnes, M. R., Finer, S., & Mathur, R. (2026) · PLoS Medicine · doi:10.1371/journal.pmed.1005196
Association of serum fibroblast growth factor 19 with DKD as assessed by the UACR and eGFR in patients with type 2 diabetes
Jia, Y., Liu, S., Xu, T., Cao, X., Shen, L., & Tang, M. (2026) · Endocrine Research · doi:10.1080/07435800.2026.2727501
Trends in type 1 and type 2 diabetic kidney disease in China, the USA, and the UK, 1990–2023
Yang, Z., Wei, X., Jiang, S., Sun, S., Zhou, J., Li, C., Cui, W., Lu, J., & Li, W. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113524
Renal outcomes associated with sodium–glucose cotransporter 2 inhibitor use in kidney transplant recipients with type 2 or posttransplant diabetes
Guzmán, G. E., Figueroa, F., Granados, S., Arias‐Valderrama, O., Giraldo, J., & Durán, C. E. (2026) · Medicine · doi:10.1097/md.0000000000050385
Clinical utility of transient elastography for assessing prevalent coronary heart disease in individuals with type 2 diabetes mellitus
Lei, J., Sheng, J., Li, W.-B., Tao, Y., Guo, J., & Zhang, Y. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02787-1
Repurposing a prostate tumor marker: elevated FPSA/TPSA ratio as a novel non-invasive biomarker for declining eGFR in male type 2 diabetes
Zhao, S., Hu, H., Zhao, X., Zhang, L., & Niu, D. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1905743
Individual and Contextual Socioeconomic Position on Type 2 Diabetes Risk in LMICs: A Multilevel Analysis
Fahimi, R., Alrubayyi, A., Hassan, M., Barber, T. M., & Uthman, O. A. (2026) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.70400
Stepwise Design of a High Signal-to-Background Ratio Dual-Emission Probe for Imaging Mitochondrial HClO and Microenvironmental Changes in Diabetic Liver and Kidney Injury
Zhang, H., Deng, M., Huang, J., Zhai, Z., Wen, Q., Liao, S., Wang, X., Cheng, D., He, L., & Li, S. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c03681
Nonlinear association of NPAR with diabetic nephropathy: evidence from a cross-sectional studyPreprint
Zan, Y., Qiu, J., Feng, J., Zhou, H., Li, J., Xu, S., Fang, L., Zhan, J., & Liu, J. (2026) · Research Square · doi:10.21203/rs.3.rs-10974439/v1
Association between depression and the development of end-stage kidney disease in people with diabetes: A population-based cohort study.
Habte-Asres, H., Afuwape, S., Heald, A., Wheeler, D. C., & Forbes, A. (2026) · Diabetic Medicine · doi:10.1111/dme.70481
Heterogeneous 30-day readmission risk in diabetic kidney disease: a nationwide analysis stratified by phenotype, age, and socioeconomic status
Zhu, Q., Ge, Y., Wang, T., Dong, H., Liu, M., Xu, Z., Yin, P., & Liu, J. (2026) · International Urology and Nephrology · doi:10.1007/s11255-026-05415-7
Albuminuria, glomerular filtration rate, and fracture among U.S. adults with and without type 2 diabetes
Hsu, S., Zelnick, L. R., de Boer, I. H., Rubin, M. R., & Nickolas, T. L. (2026) · JBMR Plus · doi:10.1093/jbmrpl/ziag166
Adjunctive Fucoidan, Fucoxanthin, and L-carnitine Mitigate Albuminuria and Preserves eGFR Over a 12-Week Treatment Period in Diabetic Kidney Disease: A Translational Study and Proof-of-Concept Randomized Clinical Trial
Chen, C., Chang, T.-I., Chen, C.-Y., Lu, D.-E., Chu, Y.-L., Huang, N.-J., Cheng, C.-Y., Chen, T.-H., Hsieh, H., & Liu, C.-T. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158870
Urinary succinate is associated with kidney injury in type 2 diabetes mellitus: a cross-sectional analysis
Cai, T., Jiao, Y., Chen, X., Kong, X., Chen, C., Chen, H., Zhang, Y., Hua, J., Liu, X., Cai, B., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1908195
Chronic Kidney Disease: Current Insights into Epidemiology, Molecular Mechanisms, Biomarkers and Management
Bhattarai, D., Nwaduru, C. E., Cardoso, R. P., Pollard, S. H., Buff, M. A., Fenlon, M. R., Selim, M. A., & Zimmerman, M. A. (2026) · Life · doi:10.3390/life16111807

Authors: Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E.
Affiliations: Centers for Disease Control and Prevention (US)
Corresponding author: Pavkov, Meda E.
ORCID: Koye, Digsu N.
Magliano, Dianna J.
Nelson, Robert G.
Pavkov, Meda E.
Venue: Advances in Chronic Kidney Disease
Publisher: Elsevier BV
Published: 2018-03
Volume: 25
Issue: 2
Pages: 121-132
ISSN: 1548-5595 (ISSN-L)
DOI: 10.1053/j.ackd.2017.10.011
PMC: PMC11000253
OpenAlex: W2790284551
Cited by: 686
References: 111
Citations by year: 2026: 79 · 2025: 111 · 2024: 137 · 2023: 109 · 2022: 101 · 2021: 78 · 2020: 44 · 2019: 19 · 2018: 7
FWCI: 6.35
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Advances in Chronic Kidney Disease (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (CC999999)
Topics: Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
Keywords: diabetes mellitus, chronic kidney disease, type 2 diabetes, end-stage renal disease, diabetes prevalence, diabetes incidence, diabetes mortality, cardiovascular disease, low- and middle-income countries, disease awareness
MeSH terms: Diabetes Mellitus, Type 2, Diabetic Nephropathies, Humans, Global Health, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Global Epidemiology of Diabetes and Kidney Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks